Clinical Research Directory
Browse clinical research sites, groups, and studies.
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Sponsor: AdventHealth Translational Research Institute
Summary
The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of liver tissue collected during standard of care liver biopsies. Paired blood/urine samples, FibroScan and relevant data will also be collected.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1250
Start Date
2021-04-22
Completion Date
2026-03
Last Updated
2025-03-13
Healthy Volunteers
Yes
Conditions
Interventions
Standard of care liver biopsy
Patients undergoing a standard of care liver biopsy for any reason who are willing to participate will be consented for collecting additional biopsy tissue for research purposes. 1-2 additional biopsy tissue cores will be collected for research. Liver tissue will be biobanked for future use.
Fibroscan
A FibroScan will be performed to evaluate longitudinal changes in liver fat and fibrosis.
Biospecimen Collection
Blood and urine will be collected.
Locations (1)
AdventHealth Translational Research Institute
Orlando, Florida, United States